The proteasome activator PA28γ, a negative regulator of p53, is transcriptionally up-regulated by p53

International Journal of Molecular Sciences

Volumn 15, Issue 2, 2014, Pages 2573-2584

  Wan, Zhen Xing ^a   Yuan, Dong Mei ^a   Zhuo, Yi Ming ^a   Yi, Xin ^a   Zhou, Ji ^a   Xu, Zao Xu ^a   Zhou, Jian Lin ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

Author keywords

Negative feedback regulation; p53; PA28 ; Promoter; PSME3; Transcription regulation

Indexed keywords

AUTOANTIGEN; KI ANTIGEN; MESSENGER RNA; PROTEASOME; PROTEIN BINDING; PROTEIN P53; RECOMBINANT PROTEIN; SMALL INTERFERING RNA;

ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DNA RESPONSIVE ELEMENT; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; PROMOTER REGION; RNA INTERFERENCE; UPREGULATION;

AUTOANTIGENS; HEK293 CELLS; HUMANS; PROMOTER REGIONS, GENETIC; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; RECOMBINANT PROTEINS; RESPONSE ELEMENTS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84893899928     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15022573     Document Type: Article

References (28)

1. Tanaka, K. The proteasome: Overview of structure and functions. Proc. Jpn. Acad. Ser. B 2009, 85, 12-36.
2. Mao, I.; Liu, J.; Li, X.; Luo, H. REGγ, a proteasome activator and beyond? Cell. Mol. Life Sci. 2008, 65, 3971-3980.
3. Yu, G.; Zhao, Y.; He, J.; Lonard, D.M.; Mao, C.A.; Wang, G.; Li, M.; Li, X. Comparative analysis of REGγ expression in mouse and human tissues. J. Mol. Cell Biol. 2010, 2, 192-198.
4. Murata, S.; Kawahara, H.; Tohma, S.; Yamamoto, K.; Kasahara, M.; Nabeshima, Y.; Tanaka, K.; Chiba, T. Growth retardation in mice lacking the proteasome activator PA28γ. J. Biol. Chem. 1999, 274, 38211-38215.
5. Chen, X.; Barton, L.F.; Chi, Y.; Clurman, B.E.; Roberts, J.M. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGγ proteasome. Mol. Cell 2007, 26, 843-852.
6. Li, X.; Amazit, L.; Long, W.; Lonard, D.M.; Monaco, J.J.; O'Malley, B.W. Ubiquitin-and ATP-independent proteolytic turnover of p21 by the REGγ-proteasome pathway. Mol. Cell 2007, 26, 831-842.
7. Kobayashi, T.; Wang, J.; Al-Ahmadie, H.; Abate-Shen, C. ARF regulates the stability of p16 protein via REGγ-dependent proteasome degradation. Mol. Cancer Res. 2013, 11, 828-833.
8. Zhang, Z.; Zhang, R. Proteasome activator PA28γ regulates p53 by enhancing its MDM2-mediated degradation. EMBO J. 2008, 27, 852-864.
9. Liu, J.; Yu, G.; Zhao, Y.; Zhao, D.; Wang, Y.; Wang, L.; Liu, J.; Li, L.; Zeng, Y.; Dang, Y.; et al. REGγ modulates p53 activity by regulating its cellular localization. J. Cell Sci. 2010, 123, 4076-4084.
10. Roessler, M.; Rollinger, W.; Mantovani-Endl, L.; Hagmann, M.L.; Palme, S.; Berndt, P.; Engel, A.M.; Pfeffer, M.; Karl, J.; Bodenmüller, H.; et al. Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis. Mol. Cell Proteomics 2006, 5, 2092-2101.
11. Okamura, T.; Taniguchi, S.; Ohkura, T.; Yoshida, A.; Shimizu, H.; Sakai, M.; Maeta, H.; Fukui, H.; Ueta, Y.; Hisatome I.; et al. Abnormally high expression of proteasome activator-γ in thyroid neoplasm. J. Clin. Endocrinol. Metab. 2003, 88, 1374-1383.
12. Wang, X.; Tu, S.; Tan, J.; Tian, T.; Ran, L.; Rodier, J.F.; Ren, G. REGγ: A potential marker in breast cancer and effect on cell cycle and proliferation of breast cancer cell. Med. Oncol. 2011, 28, 31-41.
13. Li, L.P.; Cheng, W.B.; Li, H.; Li, W.; Yang, H.; Wen, D.H.; Tang, Y.D. Expression of proteasome activator REGγ in human laryngeal carcinoma and associations with tumor suppressor proteins. Asian Pac. J. Cancer Prev. 2012, 13, 2699-2703.
14. Li, X.; Lonard, D.M.; Jung, S.Y.; Malovannaya, A.; Feng, Q.; Qin, J.; Tsai, S.Y.; Tsai, M.J.; O'Malley B.W. The SRC-3/AIB1 coactivator is degraded in a ubiquitin-and ATP-independent manner by the REGγ proteasome. Cell 2006, 124, 381-392.
15. Moriishi, K.; Okabayashi, T.; Nakai, K.; Moriya, K.; Koike, K.; Murata, S.; Chiba, T.; Tanaka, K.; Suzuki, E.; Suzuki, T.; et al. Proteasome activator PA28γ-dependent nuclear retention and degradation of hepatitis C virus core protein. J. Virol. 2003, 77, 10237-10249.
16. Ying, H.; Furuya, F.; Zhao, L.; Araki, O.; West, B.L.; Hanover, J.A.; Willingham, M.C.; Cheng, S.Y. Aberrant accumulation of PTTG1 induced by a mutated thyroid hormone β receptor inhibits mitotic progression. J. Clin. Invest. 2006, 116, 2972-2984.
17. Levy-Barda, A.; Lerenthal, Y.; Davis, A.J.; Chung, Y.M.; Essers, J.; Shao, Z.; van Vliet, N.; Chen, D.J.; Hu, M.C.T.; Kanaar, R.; et al. Involvement of the nuclear proteasome activator PA28γ in the cellular response to DNA double-strand breaks. Cell Cycle 2011, 10, 4300-4310.
18. Zannini, L.; Lecis, D.; Buscemi, G.; Carlessi, L.; Gasparini, P.; Fontanella, E.; Lisanti, S.; Barton, L.; Delia, D. REGγ proteasome activator is involved in the maintenance of chromosomal stability. Cell Cycle 2008, 7, 504-512.
19. Solovyev, V.; Kosarev, P.; Seledsov, I.; Vorobyev, D. Automatic annotation of eukaryotic genes, pseudogenes and promoters. Genome Biol. 2006, 7, S10.
20. Solovyev, V.; Salamov, A. The Gene-Finder computer tools for analysis of human and model organisms genome sequences. Proc. Int. Conf. Intell. Syst. Mol. Biol. 1997, 5, 294-302.
21. Reese, M.G. Application of a time-delay neural network to promoter annotation in the Drosophila melanogaster genome. Comput. Chem. 2001, 26, 51-56.
22. Ohler, U.; Stemmer, G.; Harbeck, S.; Niemann, H. Stochastic segment models of eukaryotic promoter regions. Pac. Symp. Biocomput. 2000, 5, 377-388.
23. Maruyama, K.; Sugano, S. Oligo-capping: A simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. Gene 1994, 138, 171-174.
24. Broos, S.; Hulpiau, P.; Galle, J.; Hooghe, B.; van Roy, F.; de Bleser, P. ConTra v2: A tool to identify transcription factor binding sites across species, update 2011. Nucleic Acids Res. 2011, 39, W74-W78.
25. Cartharius, K.; Frech, K.; Grote, K.; Klocke, B.; Haltmeier, M.; Klingenhoff, A.; Frisch, M.; Bayerlein, M.; Werner, T. MatInspector and beyond: Promoter analysis based on transcription factor binding sites. Bioinformatics 2005, 21, 2933-2942.
26. Wu, X.; Bayle, J.H.; Olson, D.; Levine, A.J. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 1993, 7, 1126-1132.
27. Zhou, J.; Qiao, X.; Xiao, L.; Sun, W.; Wang, L.; Li, H.; Wu, Y.; Ding, X.; Hu, X.; Zhou, C.; et al. Identification and characterization of the novel protein CCDC106 that interacts with p53 and promotes its degradation. FEBS Lett. 2010, 584, 1085-1090.
28. Zhang, H.; Chen, H.; Luo, H.; An, J.; Sun, L.; Mei, L.; He, C.; Jiang, L.; Jiang, W.; Xia, K.; et al. Functional analysis of Waardenburg syndrome-associated PAX3 and SOX10 mutations: Report of a dominant-negative SOX10 mutation in Waardenburg syndrome type II. Hum. Genet. 2012, 131, 491-503.